US health agency to expand access to GLP-1 weight-loss drugs

Core Viewpoint - The U.S. Centers for Medicare and Medicaid Services will negotiate drug pricing with manufacturers of GLP-1 medications to enhance access to weight loss drugs [1] Group 1: Drug Pricing Negotiation - The negotiation aims to lower costs for GLP-1 medications, which are known for their effectiveness in weight loss [1] - This initiative reflects a broader trend in the U.S. healthcare system to control drug prices and improve affordability for patients [1]